Selected research
Market Analysis & Forecast
Global Heart Surgery Perfusion Service Market Analysis and Forecast 2026-2032
Market perspective
The global Heart Surgery Perfusion Service market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for Heart Surgery Perfusion Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Heart Surgery Perfusion Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Heart Surgery Perfusion Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Heart Surgery Perfusion Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of Heart Surgery Perfusion Service include St George, Comprehensive Care Services, Keystone Perfusion Services, SpecialtyCare, Perfusion Solution, PROCIRCA, Vivacity Perfusion and Cambridge Perfusion Services, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Heart Surgery Perfusion Service, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Heart Surgery Perfusion Service, also provides the revenue of main regions and countries. Of the upcoming market potential for Heart Surgery Perfusion Service, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Heart Surgery Perfusion Service revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Heart Surgery Perfusion Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Heart Surgery Perfusion Service revenue, projected growth trends, production technology, application and end-user industry.
Heart Surgery Perfusion Service Segment by Company
St George
Comprehensive Care Services
Keystone Perfusion Services
SpecialtyCare
Perfusion Solution
PROCIRCA
Vivacity Perfusion
Cambridge Perfusion Services
Heart Surgery Perfusion Service Segment by Type
Cardiopulmonary Bypass (CPB)
Extracorporeal Membrane Oxygenation (ECMO)
Isolated Limb Perfusion
Heart Surgery Perfusion Service Segment by Application
Adult
Children
Heart Surgery Perfusion Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Heart Surgery Perfusion Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Heart Surgery Perfusion Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Heart Surgery Perfusion Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Heart Surgery Perfusion Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Heart Surgery Perfusion Service company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Heart Surgery Perfusion Service revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Cardiopulmonary Bypass (CPB)
- Extracorporeal Membrane Oxygenation (ECMO)
- Isolated Limb Perfusion
Applications
- Adult
- Children
Companies covered
- St George
- Comprehensive Care Services
- Keystone Perfusion Services
- SpecialtyCare
- Perfusion Solution
- PROCIRCA
- Vivacity Perfusion
- Cambridge Perfusion Services
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Heart Surgery Perfusion Service Market by Type
- 1.2.1 Global Heart Surgery Perfusion Service Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Cardiopulmonary Bypass (CPB)
- 1.2.3 Extracorporeal Membrane Oxygenation (ECMO)
- 1.2.4 Isolated Limb Perfusion
- 1.3 Heart Surgery Perfusion Service Market by Application
- 1.3.1 Global Heart Surgery Perfusion Service Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Adult
- 1.3.3 Children
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Heart Surgery Perfusion Service Market Dynamics
- 2.1 Heart Surgery Perfusion Service Industry Trends
- 2.2 Heart Surgery Perfusion Service Industry Drivers
- 2.3 Heart Surgery Perfusion Service Industry Opportunities and Challenges
- 2.4 Heart Surgery Perfusion Service Industry Restraints
3 Global Growth Perspective
- 3.1 Global Heart Surgery Perfusion Service Market Perspective (2021-2032)
- 3.2 Global Heart Surgery Perfusion Service Growth Trends by Region
- 3.2.1 Global Heart Surgery Perfusion Service Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Heart Surgery Perfusion Service Market Size by Region (2021-2026)
- 3.2.3 Global Heart Surgery Perfusion Service Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global Heart Surgery Perfusion Service Revenue by Players
- 4.1.1 Global Heart Surgery Perfusion Service Revenue by Players (2021-2026)
- 4.1.2 Global Heart Surgery Perfusion Service Revenue Market Share by Players (2021-2026)
- 4.1.3 Global Heart Surgery Perfusion Service Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Heart Surgery Perfusion Service Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global Heart Surgery Perfusion Service Key Players Headquarters & Area Served
- 4.4 Global Heart Surgery Perfusion Service Players, Product Type & Application
- 4.5 Global Heart Surgery Perfusion Service Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Heart Surgery Perfusion Service Market CR5 and HHI
- 4.6.3 2025 Heart Surgery Perfusion Service Tier 1, Tier 2, and Tier 3
5 Heart Surgery Perfusion Service Market Size by Type
- 5.1 Global Heart Surgery Perfusion Service Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global Heart Surgery Perfusion Service Revenue by Type (2021-2032)
- 5.3 Global Heart Surgery Perfusion Service Revenue Market Share by Type (2021-2032)
6 Heart Surgery Perfusion Service Market Size by Application
- 6.1 Global Heart Surgery Perfusion Service Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global Heart Surgery Perfusion Service Revenue by Application (2021-2032)
- 6.3 Global Heart Surgery Perfusion Service Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 St George
- 7.1.1 St George Company Information
- 7.1.2 St George Business Overview
- 7.1.3 St George Heart Surgery Perfusion Service Revenue and Gross Margin (2021-2026)
- 7.1.4 St George Heart Surgery Perfusion Service Product Portfolio
- 7.1.5 St George Recent Developments
- 7.2 Comprehensive Care Services
- 7.2.1 Comprehensive Care Services Company Information
- 7.2.2 Comprehensive Care Services Business Overview
- 7.2.3 Comprehensive Care Services Heart Surgery Perfusion Service Revenue and Gross Margin (2021-2026)
- 7.2.4 Comprehensive Care Services Heart Surgery Perfusion Service Product Portfolio
- 7.2.5 Comprehensive Care Services Recent Developments
- 7.3 Keystone Perfusion Services
- 7.3.1 Keystone Perfusion Services Company Information
- 7.3.2 Keystone Perfusion Services Business Overview
- 7.3.3 Keystone Perfusion Services Heart Surgery Perfusion Service Revenue and Gross Margin (2021-2026)
- 7.3.4 Keystone Perfusion Services Heart Surgery Perfusion Service Product Portfolio
- 7.3.5 Keystone Perfusion Services Recent Developments
- 7.4 SpecialtyCare
- 7.4.1 SpecialtyCare Company Information
- 7.4.2 SpecialtyCare Business Overview
- 7.4.3 SpecialtyCare Heart Surgery Perfusion Service Revenue and Gross Margin (2021-2026)
- 7.4.4 SpecialtyCare Heart Surgery Perfusion Service Product Portfolio
- 7.4.5 SpecialtyCare Recent Developments
- 7.5 Perfusion Solution
- 7.5.1 Perfusion Solution Company Information
- 7.5.2 Perfusion Solution Business Overview
- 7.5.3 Perfusion Solution Heart Surgery Perfusion Service Revenue and Gross Margin (2021-2026)
- 7.5.4 Perfusion Solution Heart Surgery Perfusion Service Product Portfolio
- 7.5.5 Perfusion Solution Recent Developments
- 7.6 PROCIRCA
- 7.6.1 PROCIRCA Company Information
- 7.6.2 PROCIRCA Business Overview
- 7.6.3 PROCIRCA Heart Surgery Perfusion Service Revenue and Gross Margin (2021-2026)
- 7.6.4 PROCIRCA Heart Surgery Perfusion Service Product Portfolio
- 7.6.5 PROCIRCA Recent Developments
- 7.7 Vivacity Perfusion
- 7.7.1 Vivacity Perfusion Company Information
- 7.7.2 Vivacity Perfusion Business Overview
- 7.7.3 Vivacity Perfusion Heart Surgery Perfusion Service Revenue and Gross Margin (2021-2026)
- 7.7.4 Vivacity Perfusion Heart Surgery Perfusion Service Product Portfolio
- 7.7.5 Vivacity Perfusion Recent Developments
- 7.8 Cambridge Perfusion Services
- 7.8.1 Cambridge Perfusion Services Company Information
- 7.8.2 Cambridge Perfusion Services Business Overview
- 7.8.3 Cambridge Perfusion Services Heart Surgery Perfusion Service Revenue and Gross Margin (2021-2026)
- 7.8.4 Cambridge Perfusion Services Heart Surgery Perfusion Service Product Portfolio
- 7.8.5 Cambridge Perfusion Services Recent Developments
8 North America
- 8.1 North America Heart Surgery Perfusion Service Revenue (2021-2032)
- 8.2 North America Heart Surgery Perfusion Service Revenue by Type (2021-2032)
- 8.2.1 North America Heart Surgery Perfusion Service Revenue by Type (2021-2026)
- 8.2.2 North America Heart Surgery Perfusion Service Revenue by Type (2027-2032)
- 8.3 North America Heart Surgery Perfusion Service Revenue Share by Type (2021-2032)
- 8.4 North America Heart Surgery Perfusion Service Revenue by Application (2021-2032)
- 8.4.1 North America Heart Surgery Perfusion Service Revenue by Application (2021-2026)
- 8.4.2 North America Heart Surgery Perfusion Service Revenue by Application (2027-2032)
- 8.5 North America Heart Surgery Perfusion Service Revenue Share by Application (2021-2032)
- 8.6 North America Heart Surgery Perfusion Service Revenue by Country
- 8.6.1 North America Heart Surgery Perfusion Service Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America Heart Surgery Perfusion Service Revenue by Country (2021-2026)
- 8.6.3 North America Heart Surgery Perfusion Service Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe Heart Surgery Perfusion Service Revenue (2021-2032)
- 9.2 Europe Heart Surgery Perfusion Service Revenue by Type (2021-2032)
- 9.2.1 Europe Heart Surgery Perfusion Service Revenue by Type (2021-2026)
- 9.2.2 Europe Heart Surgery Perfusion Service Revenue by Type (2027-2032)
- 9.3 Europe Heart Surgery Perfusion Service Revenue Share by Type (2021-2032)
- 9.4 Europe Heart Surgery Perfusion Service Revenue by Application (2021-2032)
- 9.4.1 Europe Heart Surgery Perfusion Service Revenue by Application (2021-2026)
- 9.4.2 Europe Heart Surgery Perfusion Service Revenue by Application (2027-2032)
- 9.5 Europe Heart Surgery Perfusion Service Revenue Share by Application (2021-2032)
- 9.6 Europe Heart Surgery Perfusion Service Revenue by Country
- 9.6.1 Europe Heart Surgery Perfusion Service Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe Heart Surgery Perfusion Service Revenue by Country (2021-2026)
- 9.6.3 Europe Heart Surgery Perfusion Service Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China Heart Surgery Perfusion Service Revenue (2021-2032)
- 10.2 China Heart Surgery Perfusion Service Revenue by Type (2021-2032)
- 10.2.1 China Heart Surgery Perfusion Service Revenue by Type (2021-2026)
- 10.2.2 China Heart Surgery Perfusion Service Revenue by Type (2027-2032)
- 10.3 China Heart Surgery Perfusion Service Revenue Share by Type (2021-2032)
- 10.4 China Heart Surgery Perfusion Service Revenue by Application (2021-2032)
- 10.4.1 China Heart Surgery Perfusion Service Revenue by Application (2021-2026)
- 10.4.2 China Heart Surgery Perfusion Service Revenue by Application (2027-2032)
- 10.5 China Heart Surgery Perfusion Service Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Heart Surgery Perfusion Service Revenue (2021-2032)
- 11.2 Asia Heart Surgery Perfusion Service Revenue by Type (2021-2032)
- 11.2.1 Asia Heart Surgery Perfusion Service Revenue by Type (2021-2026)
- 11.2.2 Asia Heart Surgery Perfusion Service Revenue by Type (2027-2032)
- 11.3 Asia Heart Surgery Perfusion Service Revenue Share by Type (2021-2032)
- 11.4 Asia Heart Surgery Perfusion Service Revenue by Application (2021-2032)
- 11.4.1 Asia Heart Surgery Perfusion Service Revenue by Application (2021-2026)
- 11.4.2 Asia Heart Surgery Perfusion Service Revenue by Application (2027-2032)
- 11.5 Asia Heart Surgery Perfusion Service Revenue Share by Application (2021-2032)
- 11.6 Asia Heart Surgery Perfusion Service Revenue by Country
- 11.6.1 Asia Heart Surgery Perfusion Service Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia Heart Surgery Perfusion Service Revenue by Country (2021-2026)
- 11.6.3 Asia Heart Surgery Perfusion Service Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Heart Surgery Perfusion Service Revenue (2021-2032)
- 12.2 SAMEA Heart Surgery Perfusion Service Revenue by Type (2021-2032)
- 12.2.1 SAMEA Heart Surgery Perfusion Service Revenue by Type (2021-2026)
- 12.2.2 SAMEA Heart Surgery Perfusion Service Revenue by Type (2027-2032)
- 12.3 SAMEA Heart Surgery Perfusion Service Revenue Share by Type (2021-2032)
- 12.4 SAMEA Heart Surgery Perfusion Service Revenue by Application (2021-2032)
- 12.4.1 SAMEA Heart Surgery Perfusion Service Revenue by Application (2021-2026)
- 12.4.2 SAMEA Heart Surgery Perfusion Service Revenue by Application (2027-2032)
- 12.5 SAMEA Heart Surgery Perfusion Service Revenue Share by Application (2021-2032)
- 12.6 SAMEA Heart Surgery Perfusion Service Revenue by Country
- 12.6.1 SAMEA Heart Surgery Perfusion Service Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA Heart Surgery Perfusion Service Revenue by Country (2021-2026)
- 12.6.3 SAMEA Heart Surgery Perfusion Service Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst